166 related articles for article (PubMed ID: 6803262)
1. Sorbinil protection of lens protein components and cell hydration during diabetic cataract formation.
Beyer-Mears A; Cruz E; Nicolas-Alexandre J; Varagiannis E
Pharmacology; 1982; 24(3):193-200. PubMed ID: 6803262
[TBL] [Abstract][Full Text] [Related]
2. Xanthone-2-carboxylic acid effect on lens growth, hydration and proteins during diabetic cataract development.
Beyer-Mears A; Cruz E; Nicolas-Alexandre J; Varagiannis E
Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):166-76. PubMed ID: 6817723
[TBL] [Abstract][Full Text] [Related]
3. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract.
Beyer-Mears A; Kelly K; Cruz E
Pharmacology; 1985; 31(3):170-9. PubMed ID: 3931105
[TBL] [Abstract][Full Text] [Related]
4. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E; Varagiannis E
Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
[TBL] [Abstract][Full Text] [Related]
5. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
Beyer-Mears A; Cruz E
Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
[TBL] [Abstract][Full Text] [Related]
6. Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lens.
Yeh LA; Rafford CE; Beyer TA; Hutson NJ
Metabolism; 1986 Apr; 35(4 Suppl 1):4-9. PubMed ID: 3083208
[TBL] [Abstract][Full Text] [Related]
7. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
8. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
Datiles MB; Fukui H
Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
[TBL] [Abstract][Full Text] [Related]
9. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
10. Nonosmotic diabetic cataracts.
Malone JI; Lowitt S; Cook WR
Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
[TBL] [Abstract][Full Text] [Related]
11. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
Datiles M; Fukui H; Kuwabara T; Kinoshita JH
Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
Beyer-Mears A; Diecke FP; Mistry K; Cruz E
Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
Unakar NJ; Tsui JY
Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
[TBL] [Abstract][Full Text] [Related]
14. The effect of an aldose reductase inhibitor (Sorbinil) on the level of metabolites in lenses of diabetic rats.
Gonzalez AM; Sochor M; McLean P
Diabetes; 1983 May; 32(5):482-5. PubMed ID: 6404681
[TBL] [Abstract][Full Text] [Related]
15. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
[No Abstract] [Full Text] [Related]
16. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
Gonzalez AM; Sochor M; Hothersall JS; McLean P
Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
[TBL] [Abstract][Full Text] [Related]
17. The polyol pathway in retinal microangiopathy.
Robison WG; Kinoshita JH; Kador PF
Drugs; 1986; 32 Suppl 2():19-22. PubMed ID: 3098542
[TBL] [Abstract][Full Text] [Related]
18. Prefeeding of aldose reductase inhibitor and galactose cataractogenesis.
Unakar NJ; Tsui JY; Johnson MJ
Curr Eye Res; 1989 Oct; 8(10):997-1010. PubMed ID: 2558845
[TBL] [Abstract][Full Text] [Related]
19. Medical therapy in the prevention of cataract.
Brown NA; Bron AJ
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 7)():748-54. PubMed ID: 3938085
[TBL] [Abstract][Full Text] [Related]
20. The penetration of Sorbinil, an aldose reductase inhibitor, into lens, aqueous humour and erythrocytes of patients undergoing cataract extraction.
Crabbe MJ; Petchey M; Burgess SE; Cheng H
Exp Eye Res; 1985 Jan; 40(1):95-9. PubMed ID: 3920064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]